Mark A. Rosenberg, M.D., is president of The Institute for Healthy Aging and director of the American Academy of Anti-Aging Medicine's Fellowship in Integrative Cancer Therapies.
With numerous certifications in several different fields of medicine, psychology and fitness. Rosenberg has a wide breadth of experience in both the public and private sector with particular expertise in the mechanism of cancer treatment failure.
His work has been published in trade and academic journals and he currently is researching new compounds to treat cancer and obesity, including receiving approval status for an investigational new drug that works with chemotherapy and a patent pending for an oral appetite suppressant.
To learn more, visit his Advanced Medical Therapeutics website.